MCP-2/CCL8 Level Associated With Suicidal Ideation in Elderly Men With Major Depression

2020 ◽  
Vol 24 (3) ◽  
pp. 467-476
Author(s):  
Mu-N Liu ◽  
Shih-Jen Tsai ◽  
Heng-Liang Yeh ◽  
Chih-Ching Wu ◽  
Ching-Po Lin
2013 ◽  
pp. n/a-n/a ◽  
Author(s):  
Philip J. Batterham ◽  
Helen Christensen ◽  
Alison L. Calear

CNS Spectrums ◽  
2021 ◽  
pp. 1-25
Author(s):  
Mao-Hsuan Huang ◽  
Mu-Hong Chen ◽  
Ju-Wei Hsu ◽  
Kai-Lin Huang ◽  
Shih-Jen Tsai ◽  
...  

2020 ◽  
pp. 1-7
Author(s):  
Mira Lutzman ◽  
Eliane Sommerfeld ◽  
Sarah Ben-David

Abstract Objectives: Suicide in the elderly is a complex and significant public health problem. The purpose of our study was to examine the role of loneliness and social integration as potential mediators in the relationship between physical pain and suicidal ideation in the elderly. Design: Descriptive, bivariate correlations, and moderated mediation analyses were performed. Setting: Personal meetings were held with participants in their homes. Participants: A total of 198 elderly men aged 65 and over. Measurements: Self-report measures: Beck Scale for Suicidal Ideation, Physical pain subscale, Multidimensional Social Integration in Later Life Scale, and University of California, Los Angeles (UCLA) Loneliness Scale (Version 3). Results: Our findings showed that the association between physical pain and suicidal ideation was mediated by loneliness and social integration. Further analyses revealed that this mediation model was significant among single, but not married, men. Conclusions: Physical pain and social factors are both important in understanding suicidality in late life. Elderly single men who experience physical pain may be lonelier and less socially integrated, and these factors may contribute to higher risk of suicidal ideation.


2000 ◽  
Vol 45 (9) ◽  
pp. 822-826 ◽  
Author(s):  
Ayal Schaffer ◽  
Anthony J Levitt ◽  
R Michael Bagby ◽  
Sidney H Kennedy ◽  
Robert D Levitan ◽  
...  

CNS Spectrums ◽  
2009 ◽  
Vol 14 (8) ◽  
pp. 431-436 ◽  
Author(s):  
Arthur Kummer ◽  
Francisco Cardoso ◽  
Antonio Lucio Teixeira

ABSTRACTObjective: To assess the frequency of suicidal ideation and suicide attempts in patients with Parkinson's disease.Methods: The Mini International Neuropsychiatric Interview (MINI), Beck Depression Inventory (BDI), and Hamilton Rating Scale for Depression (HAM-D) were administered to 90 consecutive, non-demented Parkinson's disease patients. They were also submitted to a complete neurologic examination which included brief cognitive batteries, the Mini Mental Status Exam, and Frontal Assessment Battery. We analyzed the scores of the section of the MINI related to the risk of suicide as well as the specific questions of BDI and HAM-D concerning suicidal ideation.Results: No patient had ever attempted suicide. According to MINI, suicidal ideation was present in 13 patients (14.4%) with Parkinson's disease. All instruments assessed the risk of suicide in a similar way. Suicidal ideation was associated only with lower age (P=.022), lower age of Parkinson's disease onset (P=.021), panic disorder (P=.004), social anxiety disorder (P=.007), and major depression (P<.001). Logistic regression analysis indicated that major depression was the main predictor of suicidal ideation.Conclusion: Suicide attempts seem to be uncommon in Parkinson's disease, despite the fact that the rates of suicidal ideation are possibly elevated. Depression seems to be the most important predictor of suicidal ideation in Parkinson's disease.


1987 ◽  
Vol 151 (1) ◽  
pp. 102-106 ◽  
Author(s):  
Anastasios Georgotas ◽  
Robert E. Mccue ◽  
Eitan Friedman ◽  
Thomas B. Cooper

The effects of nortriptyline, phenelzine, and placebo on 13 symptoms of depression were compared in 75 patients, aged 55 or over, who were suffering from major depression. Nortriptyline and phenelzine were more effective than placebo in treating depression mood, guilt feelings, suicidal ideation, agitation, anxiety, loss of energy, and a.m. diurnal variation of mood. Nortriptyline was better than phenelzine or placebo in improving middle/late insomnia. Most of the symptoms did not show significant improvement until the fourth week of treatment.


2015 ◽  
Vol 52 (3) ◽  
pp. 283-288 ◽  
Author(s):  
Urun Ozer ◽  
Ejder Akgun Yildirim ◽  
Sahap Nurettin Erkoc

Sign in / Sign up

Export Citation Format

Share Document